The Supreme Court ruled criminal cases against companies can proceed without specific individuals named. This decision impacts corporate cr...

Prasol Chemicals has raised nearly Rs 150 crore from anchor investors ahead of its Rs 500-crore IPO, which opens on September 8. The specia...

Karan Bhagat acquired 1.3 lakh Novartis India shares for nearly Rs 22 crore. His firm Kyrush Investments sold an equal number of shares in ...

The Bharat Health Global Expo is expected to grow substantially. Its next edition will be four times larger than the current one. Participa...

Karnataka's industries minister will lead a delegation to France and the Netherlands. This high-level team aims to attract global companies...

Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...

Pharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...

Indian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...

Cohance Lifesciences announced an eighteen million dollar investment to strengthen its antibody-drug conjugate strategy. This includes thir...

Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...

Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...

Sun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...

Mankind Pharma has completed the sale of its entire stake in Broadway Hospitality Services. The transaction involved transferring 100 perce...

Aurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...

Argentina committed to reducing barriers for Indian pharmaceutical entry. This move will offer greater opportunities for Indian companies a...

The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...